It is notable that TNF-α has been implicated in the development and propagation of severe respiratory disorders69–71, and therapeutic strategies involving TNF inhibition have had positive clinical outcomes in treatment of severe pulmonary conditions, including idiopathic pneumonia syndrome following bone marrow transplantation72. This evidence concerns the gene TNF and ichthyosis prematurity syndrome.